Belgian startup Osimis raises €2.3 million for its collaborative medical imaging software

Osimis_press_team

Liège-based Osimis uses open source software to build innovative collaboration tools for medical imaging. Its newest solution, Lify, simplifies the exchange and consultation of medical imaging studies. The startup has just completed its third round of financing of €2.3 million to further the development of the Lily platform.

“We found in Lify a certain flexibility, responsiveness and customization of the tool that goes beyond the robustness of the system that had already been validated by our IT teams,” said Patrice Sapey, Director of the Saint-Catherine Cancer Institute in Avignon.

An expert in a global niche market, Osimis aims to strengthen its presence in Europe, North America and Asia. The Osimis team is the main contributor to the Orthanc open source project for medical imaging. Orthanc has been downloaded more than 230,000 times and is used in 192 countries. Lifyis Osimis’ proprietary platform that allows for a fast and efficient deployment of Orthanc in the health industry.

“As an initiator of the project in an academic setting thanks to the support of the University Hospital of Liège, I am delighted that we are thus opening a new page in the already long history of the free and open-source Orthanc ecosystem,” said Sébastien Jodogne, Chief Scientific Officer. “The scientific and societal impact of Orthanc has been praised internationally and is part of a philosophy of openness and dissemination of knowledge.”

​”This fundraising will enable us to accelerate the development and international expansion of the Lify platform,” said Frédéric Lambrechts, CEO. “Our goal is to improve the clinical pathway and the patient’s life across all dimensions of medical imaging. Technology and innovation are tools that must be put to the service of the patient. Our approach to this effect is to bring algorithmic innovation closer to clinical practice in the context of medical imaging. We’re currently looking for computer scientists and commercial medical technology to keep up with demand.”